Get to know what's happening behind the scenes.

Learn more



Read the latest on our blog. Let's Talk Innovation.


Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation



Press Releases

Read our latest news.

  • Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions

    Cambridge, MA
    February 2, 2017

    Agreements with DayTwo, the Weizmann Institute of Science and Caelus Health Focus on Promoting Health through Microbiome Innovation

  • Johnson & Johnson Innovation, New York State, and New York Genome Center Collaborate to Launch JLABS in New York City

    New York City
    January 9, 2017

    Johnson & Johnson Innovation LLC, New York State, and the New York Genome Center today announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in Soho and will open in 2018. The project is receiving $17 million in New York State funding.  The site will be open to biotech, pharmaceutical, medical device and consumer health companies. A Quick Fire Challenge seeking companies working in these areas, particularly startups working on cross-sector solutions to prevent intercept or cure diseases, will be launched by Johnson & Johnson Innovation, with the winner(s) eligible for one year of residency at JLABS @ NYC.

  • Johnson & Johnson Innovation’s global pursuit of cutting-edge science yields 15 new collaborations, pushing the total above 300.

    New Brunswick
    January 5, 2017

    Collaborations advance novel research across pharmaceutical, medical device and consumer healthcare sectors, in areas including 3D printing, the microbiome and immunotherapy

    Johnson & Johnson Innovation LLC today announced 15 new collaborations spanning promising scientific areas, including 3D printing, the microbiome and immunotherapy. These collaborations, which are focused on developing novel healthcare solutions in areas of high unmet need such as depression, cancer and diabetes, bring the total number of strategic transactions to more than 300 since the establishment of Johnson & Johnson Innovation.

    Download the PDF for the full press release.



Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.